Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial of aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with Pseudomonas aeruginosa completed and posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis, Lung Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-12-20